Facebook
Twitter
LinkedIn
Forward
12th Annual Houston Methodist Cancer Symposium - August 9, 2024
In-Person and Virtual attendance options are available.
NOW ACCEPTING ABSTRACTS!
Submission deadline: July 26, 2024
Click here to learn more or submit an abstract
Presented by the Houston Methodist Dr. Mary and Ron Neal Cancer Center
This annual symposium, dedicated to the science and clinical care of solid and hematologic malignancies, brings together Houston Methodist scientists and physicians from a broad spectrum of fields, including basic, clinical, and epidemiological research. A wide range of topics will be covered, from innovative translational science to clinical updates with strategies for implementation in current clinical practice. The program will provide education focused on improving patient care, research collaboration and leading medicine.
FEES
| REGISTRATION TYPE | FEE |
|---|---|
| Houston Methodist Employees | Complimentary |
| Physician (Private physician located within the Greater Houston Area) | $250 |
| Physician (Private physician located outside the Greater Houston Area) | $125 |
| Research Scientist | $40 |
| Allied Health Care Professional | $40 |
| Resident / Fellow / Student | Complimentary |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.
Target Audience
Physician scientists, practicing oncologists, physician assistants, advanced nurse practitioners, oncology nurses, residents, fellows, medical students, allied health care professionals and clinical research associates will benefit from this course.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Discuss the fundamental mechanisms of cellular immunotherapy in hematologic malignancies
- Describe the approved cell therapy options in hematologic malignancies including CAR-T cell
- Identify new cellular therapies in the pipeline for these diseases
LIVE (in-person attendance) will be held in the Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, Texas 77030.
Virtual information will be provided to registered learners at a later date.
| COURSE DIRECTORS |
| Eleni Efstathiou, MD, PhD |
| Section Chief of Genitourinary Medical Oncology Houston Methodist Oncology Partners |
| Shilpan Shah, MD |
| Assistant Professor of Clinical Medicine in Oncology, Academic Institute Houston Methodist Weill Cornell Medical College Adjunct Assistant Professor Texas A&M University College of Medicine |
Available Credit
- 6.75 AMA PRA Category 1 Credit™
Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Houston Methodist designates this Live activity for a maximum of 6.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 6.75 Attendance
Interested in exhibiting or sponsoring? Contact us for more information.
Price
FEES
| REGISTRATION TYPE | FEE |
|---|---|
| Houston Methodist Employees | Complimentary |
| Physician (Private physician located within the Greater Houston Area) | $250 |
| Physician (Private physician located outside the Greater Houston Area) | $125 |
| Research Scientist | $40 |
| Allied Health Care Professional | $40 |
| Resident / Fellow / Student | Complimentary |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.